Publication|Articles|April 10, 2026
- Pharmaceutical Executive: April 2026
- Volume 46
- Issue 3
Pharmaceutical Executive: April 2026 Interactive Digital Edition
View the Pharmaceutical Executive April 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 month ago
Capital Gainsabout 1 month ago
Aradhana Sarin: The CFO as a Catalystabout 1 month ago
How Agentic AI Is Reshaping the Launch Playbook for PharmaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5
